ARTICLE | Clinical News
Maintate bisoprolol fumarate regulatory update
September 24, 2012 7:00 AM UTC
Mitsubishi submitted a regulatory application in Japan to expand the label of Maintate bisoprolol fumarate tablets to include treatment of chronic atrial fibrillation. The selective adrenergic recept...